Team AimaGenetics – 2nd Place http://conquerxlab.com/ Deborah Zanforlin, Jakub Chudik, To-Nhu Hyunh, Jorge Sanchez, Zuby Onwuta, Luis Trapani Class 2, MIT Global Entrepreneurship Bootcamp Demo Day August 28, 2015 About the program The MIT Global Entrepreneurship Bootcamp is an intensive, week-long new ventures leadership program that gives bootcampers a taste of drinking from the firehose that all MIT students experience. It is a nexus connecting entrepreneurs from around the world to the entrepreneurship and innovation eco-system surrounding the Massachusetts Institute of Technology. https://bootcamp.mit.edu/entrepreneurship

1. aimaGeneticsMr. Paul

2. aimaGenetics

3. aimaGenetics
Patient
 Late diagnostic
 Low cure rate
 Radiation risks
Provider
 20% wrong
reading
 Could be unsafe
Insurer
 Waste $ 353
million/year
Stage 3 lung cancer
55 years old
Married
Smokes for 15 years
Two children
Covered by Insurance
The Problems
Mr. Paul

4. aimaGenetics
 Safer
 Reduce erroneous result by 75%
 50% less expensive
 Save $ 1.8 billion
AimaG1
Early detection of lung cancer
Lab

5. 42,1
million
10,
5
million
735K
US Market Potential – Lung cancer
All U.S. smokers
All U.S. 55 – 77 years
old heavy smokers
55-70 years old heavy
smokers in California
aimaGenetics

6. Cost
Savings
Saved lives
Competitive Position
aimaGenetics
CT Scan
aimaGenetics saving lives
aimaGenetics

7. National Coverage
Determination
approval
Consumables
Machine
Go To Market
Patient
Lab
Doctor
INSURER Regulatory
Agencies
aimaGenetics
aimaGenetics

8. Timeline
2015 2016 2017 2018 2019
Dev.
Clinical
Trials
IP
Prototype First Release Second Release
Clinical Trials
License
Provisional
Patent
Application FDA
IRB Launch

9. aimaGeneticsFinancial Projections
0
1,000,000
2,000,000
3,000,000
4,000,000
1 2 3 4 5 6 7 8 9 10
Units sold

10. aimaGeneticsTeam
Luis Trapani
(Business dev.)
Jorge Sanchez
(Senior Sales)
Jakub Chudik
(Tech )
Zuby Onuwuta
(Engineer)
To Nhu
(CEO)
Prevention Cancer
Researcher
Deborah Zanforlin
(CSO)
Biomedical Scientist
M.Sc. Biology Applied to Health
5 years of Experience in
Biosensors/Biotechnology/Can
cer Detection

11. aimaGenetics
$15M funding to
start saving lives

12. Appendix

13. Scientific Background

14. Economic
buyer
Hospital
Administrato
r
Lab Manager
Champion
Primary care
physicians
Patients
Patient
Advocacy
Groups
Influencers
VP Finance at
hospital &
lab
HMD
End users
Hospital &
lab tech
Veto Power
VP Finance
DECISION MAKING UNITS